Skip to main content
Erschienen in: Endocrine 3/2018

10.09.2018 | Endocrine Surgery

Dynamic changes in the distribution of facial and abdominal adipose tissue correlated with surgical treatment in acromegaly

verfasst von: Tao Xie, Hailin Ding, Mingfeng Xia, Xiaobiao Zhang, Wei Sun, Tengfei Liu, Ye Gu, Chongjing Sun, Fan Hu

Erschienen in: Endocrine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Acromegaly is a systemic metabolic disease. Growth hormone (GH) have a significant impact on adipose tissue (AT). A huge reduction of serum GH after surgical treatment may cause substantial AT redistribution. The objective of this study was to illustrate the dynamic changes in distribution of facial and abdominal AT correlated with surgical treatment in patients with acromegaly.

Methods

Abdominal AT in 17 acromegaly patients (group 1) was studied longitudinally preoperatively and 1 month to 1 year postoperatively. The facial and abdominal subcutaneous AT (fSAT and aSAT) of another 17 acromegaly patients (group 2) were compared with 7 nonfunctional pituitary adenoma (NFPA) controls.
The areas of fSAT, aSAT, and visceral adipose tissue (VAT) were obtained by MRI and quantified by image analysis software, and intrahepatic lipid (IHL) was assessed by 1H magnetic resonance spectroscopy (MRS).

Results

Abdominal adipose tissue (aSAT, VAT, and IHL) increased overall after surgical treatment. However, IHL first decreased and then continuously increased during the follow-up. Compared with the increased amount of aSAT, the fSAT amount decreased after surgical treatment. The inconsistency of this phenomenon did not appear in the NFPA control subjects.

Conclusion

The perioperative dynamic distribution of the facial and abdominal fat in acromegaly revealed regional differences in the intricate effect of GH on adipose tissue. Reduction of serum GH after surgical treatment of acromegaly was associated with dynamic increases of IHL, abdominal visceral, and subcutaneous fat, but a reduction of facial subcutaneous fat.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat C. Capatina, J.A. Wass, 60 years of neuroendocrinology: acromegaly. J. Endocrinol. 226(2), T141–T160 (2015)CrossRef C. Capatina, J.A. Wass, 60 years of neuroendocrinology: acromegaly. J. Endocrinol. 226(2), T141–T160 (2015)CrossRef
2.
Zurück zum Zitat L. Katznelson, Alterations in body composition in acromegaly. Pituitary 12, 136–142 (2009)CrossRef L. Katznelson, Alterations in body composition in acromegaly. Pituitary 12, 136–142 (2009)CrossRef
3.
Zurück zum Zitat N. Møller, J.O. Jørgensen, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30(2), 152–177 (2009)CrossRef N. Møller, J.O. Jørgensen, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30(2), 152–177 (2009)CrossRef
4.
Zurück zum Zitat J. Dal, E.O. List, J.O. Jørgensen, D.E. Berryman, Glucose and fat metabolism in acromegaly: from mice models to patient care. Neuroendocrinology 103, 96–105 (2016)CrossRef J. Dal, E.O. List, J.O. Jørgensen, D.E. Berryman, Glucose and fat metabolism in acromegaly: from mice models to patient care. Neuroendocrinology 103, 96–105 (2016)CrossRef
5.
Zurück zum Zitat N.C. Olarescu, J. Bollerslev, The impact of adipose tissue on insulin resistance in acromegaly. Trends Endocrinol. Metab. 27(4), 226–237 (2016)CrossRef N.C. Olarescu, J. Bollerslev, The impact of adipose tissue on insulin resistance in acromegaly. Trends Endocrinol. Metab. 27(4), 226–237 (2016)CrossRef
6.
Zurück zum Zitat C.M. Reyes-Vidal, H. Mojahed, W. Shen et al. Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J. Clin. Endocrinol. Metab. 100(8), 2946–2955 (2015)CrossRef C.M. Reyes-Vidal, H. Mojahed, W. Shen et al. Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J. Clin. Endocrinol. Metab. 100(8), 2946–2955 (2015)CrossRef
7.
Zurück zum Zitat M. Madsen, T. Krusenstjerna-Hafstrøm, L. Møller et al. Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a ghreceptor antagonist: a randomized clinical trial. J. Clin. Endocrinol. Metab. 97(4), 1227–1235 (2012)CrossRef M. Madsen, T. Krusenstjerna-Hafstrøm, L. Møller et al. Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a ghreceptor antagonist: a randomized clinical trial. J. Clin. Endocrinol. Metab. 97(4), 1227–1235 (2012)CrossRef
8.
Zurück zum Zitat A. Pascale, R. Pals, V. Ratziu, An overview of nonalcoholic steatohepafitis: past, present and future directions. J. Gastrointestin. Liver. Dis. 19, 415–423 (2010)PubMed A. Pascale, R. Pals, V. Ratziu, An overview of nonalcoholic steatohepafitis: past, present and future directions. J. Gastrointestin. Liver. Dis. 19, 415–423 (2010)PubMed
9.
Zurück zum Zitat S.M. Webb, X. Badia, Quality of life in acromegaly. Neuroendocrinology 103(1), 106–111 (2016)CrossRef S.M. Webb, X. Badia, Quality of life in acromegaly. Neuroendocrinology 103(1), 106–111 (2016)CrossRef
10.
Zurück zum Zitat D.E. Berryman, E.O. List, L. Sackmann-Sala et al. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm. IGF Res. 21(3), 113–123 (2011)CrossRef D.E. Berryman, E.O. List, L. Sackmann-Sala et al. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm. IGF Res. 21(3), 113–123 (2011)CrossRef
11.
Zurück zum Zitat L. Katznelson, E.R. Laws Jr, S. Melmed et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)CrossRef L. Katznelson, E.R. Laws Jr, S. Melmed et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014)CrossRef
12.
Zurück zum Zitat M. Maddalo, I. Zorza, S. Zubani et al. Validation of a free software for unsupervised assessment of abdominal fat in MRI. Phys. Med. 37, 24–31 (2017)CrossRef M. Maddalo, I. Zorza, S. Zubani et al. Validation of a free software for unsupervised assessment of abdominal fat in MRI. Phys. Med. 37, 24–31 (2017)CrossRef
13.
Zurück zum Zitat M.F. Xia, H.M. Yan, W.Y. He et al. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity 20(2), 444–452 (2012)CrossRef M.F. Xia, H.M. Yan, W.Y. He et al. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity 20(2), 444–452 (2012)CrossRef
14.
Zurück zum Zitat H.H. Hu, H.W. Kim, K.S. Nayak et al. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity 18(4), 841–847 (2010)CrossRef H.H. Hu, H.W. Kim, K.S. Nayak et al. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity 18(4), 841–847 (2010)CrossRef
15.
Zurück zum Zitat C.A. Schneider, W.S. Rasband, K.W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 201(9), 671–675 (2012)CrossRef C.A. Schneider, W.S. Rasband, K.W. Eliceiri, NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 201(9), 671–675 (2012)CrossRef
16.
Zurück zum Zitat P.U. Freda, W. Shen, S.B. Heymsfield et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J. Clin. Endocrinol. Metab. 93(6), 2334–2343 (2008)CrossRef P.U. Freda, W. Shen, S.B. Heymsfield et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J. Clin. Endocrinol. Metab. 93(6), 2334–2343 (2008)CrossRef
17.
Zurück zum Zitat A. Guleria, A. Duseja, N. Kalra et al. Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop. Gastroenterol. 34(2), 74–82 (2013)CrossRef A. Guleria, A. Duseja, N. Kalra et al. Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop. Gastroenterol. 34(2), 74–82 (2013)CrossRef
18.
Zurück zum Zitat J.H. Runge, L.P. Smits, J. Verheij et al. MR spectroscopy-derived proton density fat fraction is superior to controlled attenuation parameter for detecting and grading hepatic steatosis. Radiology 286(2), 547–556 (2018)CrossRef J.H. Runge, L.P. Smits, J. Verheij et al. MR spectroscopy-derived proton density fat fraction is superior to controlled attenuation parameter for detecting and grading hepatic steatosis. Radiology 286(2), 547–556 (2018)CrossRef
19.
Zurück zum Zitat P. Mofrad, M.J. Contos, M. Haque et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37(6), 1286–1292 (2003)CrossRef P. Mofrad, M.J. Contos, M. Haque et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37(6), 1286–1292 (2003)CrossRef
20.
Zurück zum Zitat M.A. Wagenmakers, S.H. Roerink, T.J. Maal et al. Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary 18(1), 126–134 (2015)CrossRef M.A. Wagenmakers, S.H. Roerink, T.J. Maal et al. Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary 18(1), 126–134 (2015)CrossRef
21.
Zurück zum Zitat A. Tominaga, K. Arita, K. Kurisu et al. Effects of successful adenomectomy on body composition in acromegaly. Endocr. J. 45, 335–342 (1998)CrossRef A. Tominaga, K. Arita, K. Kurisu et al. Effects of successful adenomectomy on body composition in acromegaly. Endocr. J. 45, 335–342 (1998)CrossRef
22.
Zurück zum Zitat A. Passaro, M.A. Miselli, J.M. Sanz et al. Gene expression regional differences in human subcutaneous adipose tissue. BMC Genomics 18(1), 202–213 (2017)CrossRef A. Passaro, M.A. Miselli, J.M. Sanz et al. Gene expression regional differences in human subcutaneous adipose tissue. BMC Genomics 18(1), 202–213 (2017)CrossRef
23.
Zurück zum Zitat R.J. Brummer, L. Lönn, H. Kvist, et al. Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy. Eur J Clin Invest. 23(4), 199–205 (1993)CrossRef R.J. Brummer, L. Lönn, H. Kvist, et al. Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy. Eur J Clin Invest. 23(4), 199–205 (1993)CrossRef
24.
Zurück zum Zitat E.B. Geer, J. Islam, C. Buettner, Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol. Metab. Clin. North. Am. 43(1), 75–102 (2014)CrossRef E.B. Geer, J. Islam, C. Buettner, Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol. Metab. Clin. North. Am. 43(1), 75–102 (2014)CrossRef
25.
Zurück zum Zitat J. Weiner, M. Hankir, J.T. Heiker et al. Thyroid hormones and browning of adipose tissue. Mol. Cell. Endocrinol. 458, 156–159 (2017)CrossRef J. Weiner, M. Hankir, J.T. Heiker et al. Thyroid hormones and browning of adipose tissue. Mol. Cell. Endocrinol. 458, 156–159 (2017)CrossRef
26.
Zurück zum Zitat M.A. Bredella, M. Schorr, L.E. Dichtel et al. Body composition and ectopic lipid changes with biochemical control of acromegaly. J. Clin. Endocrinol. Metab. 102(11), 4218–4225 (2017)CrossRef M.A. Bredella, M. Schorr, L.E. Dichtel et al. Body composition and ectopic lipid changes with biochemical control of acromegaly. J. Clin. Endocrinol. Metab. 102(11), 4218–4225 (2017)CrossRef
27.
Zurück zum Zitat K. Karastergiou, M.A. Bredella, M.J. Lee et al. Growth hormone receptor expression in human gluteal versus abdominal subcutaneous adipose tissue: association with body shape. Obesity 24(5), 1090–1096 (2016)CrossRef K. Karastergiou, M.A. Bredella, M.J. Lee et al. Growth hormone receptor expression in human gluteal versus abdominal subcutaneous adipose tissue: association with body shape. Obesity 24(5), 1090–1096 (2016)CrossRef
28.
Zurück zum Zitat R. Hjortebjerg, D.E. Berryman, R. Comisford et al. Insulin, IGF-1, and GH receptors are altered in an adipose tissue depot-specific manner in male mice with modified GH action. Endocrinology 158(5), 1406–1418 (2017)CrossRef R. Hjortebjerg, D.E. Berryman, R. Comisford et al. Insulin, IGF-1, and GH receptors are altered in an adipose tissue depot-specific manner in male mice with modified GH action. Endocrinology 158(5), 1406–1418 (2017)CrossRef
Metadaten
Titel
Dynamic changes in the distribution of facial and abdominal adipose tissue correlated with surgical treatment in acromegaly
verfasst von
Tao Xie
Hailin Ding
Mingfeng Xia
Xiaobiao Zhang
Wei Sun
Tengfei Liu
Ye Gu
Chongjing Sun
Fan Hu
Publikationsdatum
10.09.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1742-x

Weitere Artikel der Ausgabe 3/2018

Endocrine 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.